In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Daniela Cejas *Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Ciudad Autónoma de Buenos Aires, Argentina.ORCID 0000-0001-7418-3573 Francisco González-Espinosa *Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Ciudad Autónoma de Buenos Aires, Argentina.ORCID 0000-0002-8190-1411 Vincenzo Di PilatoDepartment of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.ORCID 0000-0002-5863-5805 Gian Maria RossoliniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID 0000-0002-9386-0434 Gabriel GutkindUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Ciudad Autónoma de Buenos Aires, Argentina.ORCID 0000-0003-1999-9785 Marcela RadiceUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Ciudad Autónoma de Buenos Aires, Argentina.ORCID 0000-0001-6061-0124 Funding
Agencia Nacional de Promoción Científica y Tecnológica PICT 2021-GRF-TII-00309Consejo Nacional de Investigaciones Científicas y Técnicas PIBAA 28720210100671COConsejo Nacional de Investigaciones Científicas y Técnicas PIP 11220200102425COUniversidad de Buenos Aires PIDAE 2025 RESCS-2024-1909 No 5184Universidad de Buenos Aires UBACyT 20020170100473BAUniversidad de Buenos Aires UBACyT 20020190100031BA
6 · The paper itselfAbstract
Here, we described the resistome and virulome of worldwide
Indexed as
Anti-Bacterial AgentsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialKlebsiella InfectionsKlebsiella pneumoniaeAminoglycosidesArgentinaBacterial Proteinsbeta-LactamasesEnterobactinGenome, BacterialGenomicsHumansHydroxamic AcidsMicrobial Sensitivity TestsPhylogenyaerobactinAminoglycosidesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseEnterobactinHydroxamic AcidssalmochelinVirulence FactorsArgentinacarbapenemaseKlebsiella pneumoniaeresistanceST25virulence
Identifiers
PMID42678163
PMCPMC13688794
What OpenQuestion holds
Textmetadata
Read underepoch 390